The lipid-lowering effect of sacubitril valsartan combined with rosuvastatin on patients with acute coronary syndrome after PCI and its impact on the cardiovascular outcomes
1.Tongji University School of Medicine, Shanghai 200092, China
2a.Department of General Practice, Shanghai Jing'an District Zhabei Central Hospital, Shanghai 200070, China
2b.Department of Cardiovascular Medicine, Shanghai Jing'an District Zhabei Central Hospital, Shanghai 200070, China
3.Department of General Practice, Tongji Hospital of Tongji University, Shanghai 200065, China
收起